WebApr 7, 2024 · Eli Lilly and Company announced today that it intends to acquire Akouos, a developer of gene therapies focused on treating hearing loss, for $12.50 per share, …
Can a Pill Fix Your Hearing? Fortune
WebOct 18, 2024 · Eli Lilly and Co. LLY, -3.61% said Tuesday it has entered an agreement to acquire Akouos Inc. akus, a company developing a portfolio of viral gene therapies for … WebOct 19, 2024 · Eli Lilly and Company LLY announced a definitive agreement to acquire Boston-based Akouos, AKUS, which is developing gene therapies for the treatment of … parasitic spleen cyst
Eli Lilly Acquires Akouos For Over $450M To Accelerate Hearing Loss ...
WebOct 18, 2024 · Eli Lilly is acquiring Akouos on the heels of the biotech receiving FDA permission to begin a clinical trial testing its gene therapy for an inherited form of … WebOct 18, 2024 · Eli Lilly ( NYSE: LLY) is acquiring hearing loss gene therapy maker Akouos ( NASDAQ: AKUS) for ~$487M plus contingent value right (CVR) worth up to $610M. Under the agreement, Lilly will... Web4 hours ago · In a report released yesterday, Geoff Meacham from Bank of America Securities maintained a Buy rating on Eli Lilly & Co ( LLY – Research Report ), with a … parasitic sort crossword